Update of the Mexican College of Rheumatology Guidelines for the Pharmacologic Treatment of Rheumatoid Arthritis

被引：33

作者：

Cardiel, Mario H. ^{[1
]}

Diaz-Borjon, Alejandro ^{[2
]}

del Mercado Espinosa, Monica Vazquez ^{[3
,4
,5
]}

Ivan Gamez-Nava, Jorge ^{[4
,6
]}

Barile Fabris, Leonor A. ^{[7
]}

Pacheco Tena, Cesar ^{[8
]}

Silveira Torre, Luis H. ^{[9
]}

Pascual Ramosh, Virginia ^{[10
]}

Goycochea Roblesi, Maria Victoria ^{[11
]}

Aguilar Arreola, Jorge Enrique ^{[3
,4
]}

Gonzalez Diaz, Veronica ^{[12
]}

Alvarez Nemegyei, Jose ^{[13
]}

del Carmen Gonzalez-Lopez, Laura ^{[4
,14
]}

Salazar Paramon, Mario ^{[15
]}

Portela Hernandez, Margarita ^{[16
]}

Castro Colin, Zully ^{[17
]}

Xibille Friedman, Daniel Xavier ^{[18
]}

Alvarez Hernandez, Everardo ^{[19
]}

Casasola Vargas, Julio ^{[19
]}

Cortes Hernandez, Miguel ^{[20
]}

Flores-Alvarado, Diana E. ^{[21
]}

Martinez Martinez, Laura A. ^{[22
]}

Vega-Morales, David ^{[23
]}

Felipe Flores-Suarez, Luis ^{[24
]}

Medrano Ramirez, Gabriel ^{[25
,26
]}

Barrera Cruz, Antonio ^{[27
,28
]}

Garcia Gonzalez, Adolfo ^{[29
]}

Lopez Lopez, Susana Marisela ^{[30
]}

Rosete Reyes, Alejandra ^{[31
]}

Espinosa Morales, Rolando ^{[32
,33
]}

机构：

[1] Hosp Gen Dr Miguel Silva, Secretaria Salud Michoacan, Unidad Invest Dr Mario Alvizouri Munoz, Morelia, Michoacan, Mexico

[2] UNAM, Hosp Angeles Lomas, Curso Especializac Med Interna, Huixquilucan, Estado De Mexic, Mexico

[3] Nuevo Hosp Civil Guadalajara Dr Juan I Menchaca, Guadalajara, Jalisco, Mexico

[4] Univ Guadalajara, Ctr Univ Ciencias Salud, Guadalajara, Jalisco, Mexico

[5] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Invest Reumatol & Sistema Musculo Esquelet, Guadalajara, Jalisco, Mexico

[6] UMAE, IMSS, Hosp Especialidades Ctr Med Nacl Occidente, Guadalajara, Jalisco, Mexico

[7] Dept Reumatol HE CMNSXXI IMSS, Mexico City, DF, Mexico

[8] Univ Autonoma Chihuahua, Fac Med, Chihuahua, Mexico

[9] Inst Nacl Cardiol Ignacio Chavez, Dept Reumatol, Curso Reumatol, Mexico City, DF, Mexico

[10] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Inmunol & Reumatol, Mexico City, DF, Mexico

[11] IMSS, Hosp Gen Reg Dr Carlos McGregor Sanchez Navarro 1, Unidad Invest Epidemiol Clin, Mexico City, DF, Mexico

[12] Antiguo Hosp Civil Guadalajara Fray Antonio Alcal, Guadalajara, Jalisco, Mexico

[13] Univ Anahuac Mayab, Escuela Med, Merida, Yucatan, Mexico

[14] Hosp Gen Reg 110 IMSS, Guadalajara, Jalisco, Mexico

[15] UMAE, Div Invest, Hosp Especialidades Ctr Med Nacl Occidente, IMSS, Guadalajara, Jalisco, Mexico

[16] Hosp Especialidades CMN SXXI, Dept Reumatol, Mexico City, DF, Mexico

[17] HGZ 27 IMSS, Dept Reumatol, Mexico City, DF, Mexico

[18] Hosp Gen Cuernavaca Dr Jose G Parres, Dept Reumatol, Cuernavaca, Morelos, Mexico

[19] Hosp Gen Mexico City, Mexico City, DF, Mexico

[20] Univ Autonoma Estado Morelos, Fac Med, Fisiol Humana, Cuernavaca, Morelos, Mexico

[21] Univ Autonoma Nuevo Leon, Hosp Univ Jose E Gonzalez, Med Interna & Reumatol, Monterrey, Nuevo Leon, Mexico

[22] Inst Nacl Cardiol Ignacio Chavez, Dept Reumatol, Mexico City, DF, Mexico

[23] Univ Autonoma Nuevo Leon, Hosp Univ Jose E Gonzalez, Monterrey, Nuevo Leon, Mexico

[24] Inst Nacl Enfermedades Resp, Clin Vasculitis Sistem Primarias, Mexico City, DF, Mexico

[25] Hosp Gen Mexico City, Serv Reumatol, Mexico City, DF, Mexico

[26] Consejo Mexicano Reumatol, Mexico City, DF, Mexico

[27] IMSS, Unidades Med Alta Especialidad, Programas Med, Mexico City, DF, Mexico

[28] IMSS, Unidades Med Alta Especialidad, Div Excelencia Clin, Area Desarrollo Guias Pract Clin Coordinac, Mexico City, DF, Mexico

[29] Hosp Gen Zona IMSS, Ciencias Med, La Paz, Baja California, Mexico

[30] Hosp Angeles del Carmen, Serv Reumatol, Guadalajara, Jalisco, Mexico

[31] Ctr Invest Farmacol & Biotecnol, Operac, Mexico City, DF, Mexico

[32] Univ Nacl Autonoma Mexico, Reumatol, Mexico City, DF, Mexico

[33] Inst Nacl Rehabil, Dept Reumatol, Mexico City, DF, Mexico

来源：

REUMATOLOGIA CLINICA | 2014年 / 10卷 / 04期

关键词：

Rheumatoid arthritis; Drug therapy; Adult; Arthritis medical care;

D O I：

10.1016/j.reuma.2013.10.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: The pharmacologic management of rheumatoid arthritis has progressed substantially over the past years. It is therefore desirable that existing information be periodically updated. There are several published international guidelines for the treatment of rheumatoid arthritis that hardly adapt to the Mexican health system because of its limited healthcare resources. Hence, it is imperative to unify the existing recommendations and to incorporate them to a set of clinical, updated recommendations; the Mexican College of Rheumatology developed these recommendations in order to offer an integral management approach of rheumatoid arthritis according to the resources of the Mexican health system. Objective: To review, update and improve the available evidence within clinical practice guidelines on the pharmacological management of rheumatoid arthritis and produce a set of recommendations adapted to the Mexican health system, according to evidence available through December 2012. Methods: The working group was composed of 30 trained and experienced rheumatologists with a high quality of clinical knowledge and judgment. Recommendations were based on the highest quality evidence from the previously established treatment guidelines, meta-analysis and controlled clinical trials for the adult population with rheumatoid arthritis. Results: During the conformation of this document, each working group settled the existing evidence from the different topics according to their experience. Finally, all the evidence and decisions were unified into a single document, treatment algorithm and drug standardization tables. Conclusions: his update of the Mexican Guidelines for the Pharmacologic Treatment of Rheumatoid Arthritis provides the highest quality information available at the time the working group undertook this review and contextualizes its use for the complex Mexican health system. (C) 2013 Elsevier Espana, S.L.All rights reserved.

引用

页码：227 / 240

页数：14

共 52 条

[1]

Alvarez-Hernandez E, 2012, REUMATOL CLIN, V8, P168, DOI [10.1016/j.reumae.2012.06.018, 10.1016/j.reuma.2012.05.002]

[2]

[Anonymous], 2012, RISK EV MIT STRAT

[3]

[Anonymous], 2010, DIAGNOSTICO TRATAMIE

[4]

Appraisal of Guidelines for Research and Evaluation II, 2009, AGR NEXT STEPS CONS

[5]

Bogas M, 2011, ACTA REUMATOL PORT, V36, P219

[6] Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety [J].

Bombardier, Claire ;

Hazlewood, Glen S. ;

Akhavan, Pooneh ;

Schieir, Orit ;

Dooley, Anne ;

Haraoui, Boulos ;

Khraishi, Majed ;

Leclercq, Sharon A. ;

Legare, Jean ;

Mosher, Dianne P. ;

Pencharz, James ;

Pope, Janet E. ;

Thomson, John ;

Thorne, Carter ;

Zummer, Michel ;

Gardam, Michael A. ;

Askling, Johan ;

Bykerk, Vivian .

JOURNAL OF RHEUMATOLOGY, 2012, 39 (08) :1583-1602

[7] Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration [J].

Brown, SL ;

Greene, MH ;

Gershon, SK ;

Edwards, ET ;

Braun, MM .

ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3151-3158

[8] BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis [J].

Bukhari, Marwan ;

Abernethy, Rikki ;

Deighton, Chris ;

Ding, Tina ;

Hyrich, Kimme ;

Lunt, Mark ;

Luqmani, Raashid ;

Kiely, Patrick ;

Bosworth, Ailsa ;

Ledingham, Jo ;

Oestoer, Andrew ;

Gadsby, Kate ;

McKenna, Frank ;

Finney, Diana ;

Dixey, Josh .

RHEUMATOLOGY, 2011, 50 (12) :2311-2313

[9]

Burgos-Vargas R, 2013, REUMATOL CLIN, V9, P106, DOI [10.1016/j.reumae.2013.01.007, 10.1016/j.reuma.2012.09.001]

[10] Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs [J].

Bykerk, Vivian P. ;